BHB810
/ BigHat Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
September 01, 2026
BigHat Biosciences Announces First Patient Dosed in Phase 1 Trial Evaluating BHB810, a Novel CDH17-Directed Antibody-Drug Conjugate, for the Treatment of Gastric Cancer and other Advanced Gastrointestinal Tumors
(Businesswire)
- "The first-in-human, Phase 1 dose escalation trial will evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of BHB810. The trial will initially enroll patients with advanced gastric and gastroesophageal (GEJ) tumors."
First-in-human • Trial status • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma
July 09, 2026
ChefHat-001: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
(clinicaltrials.gov)
- P1/2 | N=164 | Recruiting | Sponsor: BigHat Biosciences, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Colon Cancer • Colorectal Cancer • Esophageal Adenocarcinoma • Esophageal Cancer • Gastric Adenocarcinoma • Gastric Cancer • Gastroesophageal Cancer • Gastroesophageal Junction Adenocarcinoma • Gastrointestinal Cancer • Oncology • Pancreatic Cancer • Solid Tumor • CDH17
March 18, 2026
BHB810: A novel site-specific CDH17-directed VHH-Fc ADC for gastric cancer
(AACR 2026)
- "BHB810 is a novel, potentially best-in-class CDH17-directed ADC for the treatment of advanced gastric and other GI malignancies. The molecule was engineered on BigHat Biosciences's AI/ML-powered antibody design platform to maximise ADC internalization and potency against cells that express CDH17. First-in-human studies are planned for 2026, prioritizing patients with gastric cancer."
ADC • First-in-human • Gastric Cancer • Oncology • Solid Tumor • CDH17 • CLDN18 • HER-2
April 14, 2026
ChefHat-001: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
(clinicaltrials.gov)
- P1/2 | N=164 | Not yet recruiting | Sponsor: BigHat Biosciences, Inc.
New P1/2 trial • Colon Cancer • Colorectal Cancer • Esophageal Adenocarcinoma • Esophageal Cancer • Gastric Adenocarcinoma • Gastric Cancer • Gastroesophageal Cancer • Gastroesophageal Junction Adenocarcinoma • Gastrointestinal Cancer • Oncology • Pancreatic Cancer • Solid Tumor • CDH17
1 to 4
Of
4
Go to page
1